Cargando…

Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy

BACKGROUND: Familial and acquired thrombophilia are often etiologic for idiopathic hip and jaw osteonecrosis (ON), and testosterone therapy (TT) can interact with thrombophilia, worsening ON. CASE PRESENTATION: Case 1: A 62-year-old Caucasian male (previous deep venous thrombosis), on warfarin 1 yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarman, Michael Ian, Lee, Kevin, Kanevsky, Ariel, Min, Sarah, Schlam, Ilana, Mahida, Chris, Huda, Ali, Milgrom, Alexander, Goldenberg, Naila, Glueck, Charles J., Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368894/ https://www.ncbi.nlm.nih.gov/pubmed/28361003 http://dx.doi.org/10.1186/s12878-017-0076-x

Ejemplares similares

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
por: Glueck, Charles J., et al.
Publicado: (2018)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland
por: Gagala, Jacek, et al.
Publicado: (2013)

Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study
por: Shah, Parth, et al.
Publicado: (2017)

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
por: Dixon, Stephan G, et al.
Publicado: (2016)

Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia
por: Prince, Marloe, et al.
Publicado: (2016)

Long Term Anticoagulation (4–16 Years) Stops Progression of Idiopathic Hip Osteonecrosis Associated with Familial Thrombophilia
por: Glueck, Charles J., et al.
Publicado: (2015)

Thrombophilia and retinal vascular occlusion
por: Glueck, Charles J, et al.
Publicado: (2012)

Determinants of hypofibrinolysis in patients with digestive tract cancer
por: Gronostaj, Katarzyna, et al.
Publicado: (2016)

Development and application of global assays of hyper‐ and hypofibrinolysis
por: Ilich, Anton, et al.
Publicado: (2019)

Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
por: Goldenberg, Naila, et al.
Publicado: (2009)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19
por: Schrick, Diana, et al.
Publicado: (2021)

Retinal artery and vein thrombotic occlusion during pregnancy: markers for familial thrombophilia and adverse pregnancy outcomes
por: Kurtz, Will S, et al.
Publicado: (2016)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis
por: Kopytek, Magdalena, et al.
Publicado: (2023)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Thrombophilia and Pregnancy Complications
por: Simcox, Louise E., et al.
Publicado: (2015)

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
por: Bryk-Wiązania, Agata Hanna, et al.
Publicado: (2021)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

Lopinavir/ritonavir/prednisone: Knee osteonecrosis and its worsening: case report
Publicado: (2021)

Thrombophilia and pregnancy
por: Kupferminc, Michael J
Publicado: (2003)

Hereditary thrombophilia
por: Khan, Salwa, et al.
Publicado: (2006)

Thrombophilia in hyperhomocysteinemia
por: Sharma, Vishal, et al.
Publicado: (2010)

Hereditary thrombophilia
por: Dautaj, Astrit, et al.
Publicado: (2019)

Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis
por: Meltzer, Mirjam E, et al.
Publicado: (2008)

Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model
por: Campos Nogueira, Yzabella Alves, et al.
Publicado: (2019)

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
por: Glueck, Charles J., et al.
Publicado: (2016)

Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy
por: Jetty, Vybhav, et al.
Publicado: (2017)

Prenatal Testosterone Exposure Worsen the Reproductive Performance of Male Rat at Adulthood
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2013)

The Role of Thrombophilia in Pregnancy
por: Battinelli, Elisabeth M., et al.
Publicado: (2013)

Thrombophilia testing in the inpatient setting: impact of an educational intervention
por: Kwang, Henry, et al.
Publicado: (2019)

Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study
por: Choi, Joshua, et al.
Publicado: (2017)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
por: Hamam, Ahmed, et al.
Publicado: (2022)

Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
por: Bryk, Agata H., et al.
Publicado: (2019)

Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
por: Blasi, Annabel, et al.
Publicado: (2019)

Recurrent Pregnancy Loss and Thrombophilia
por: D’Uva, Maristella, et al.
Publicado: (2010)

Idiopathic venous thromboembolism and thrombophilia
por: Sinescu, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uum4kk9qb57m33ocg0mhjlfubq